Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)

Addiction

Volumn 103, Issue 6, 2008, Pages 1048-1050

  Boyer, Edward W ^a   Babu, Kavita M ^a   Adkins, Jessica E ^b   McCurdy, Christopher R ^b,c   Halpern, John H ^d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

Dependence; Kratom; Molecular screening; Opioid; Opioid replacement; Withdrawal

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; DELTA OPIATE RECEPTOR; HYDROMORPHONE; KAPPA OPIATE RECEPTOR; MITRAGYNIA SPECIOSA KORTH EXTRACT; MITRAGYNINE; MODAFINIL; MU OPIATE RECEPTOR; PLANT EXTRACT;

ADULT; ARTICLE; BINDING AFFINITY; CASE REPORT; CHRONIC PAIN; CLINICAL FEATURE; DISEASE COURSE; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; HERB; HIGH THROUGHPUT SCREENING; HUMAN; MALE; MITRAGYNIA SPECIOSA KORTH; OPIATE ADDICTION; RECEPTOR AFFINITY; SELF CARE; SYMPTOM; THORAX OUTLET SYNDROME; TONIC CLONIC SEIZURE; WITHDRAWAL SYNDROME;

ADULT; ANALGESICS, OPIOID; HUMANS; HYDROMORPHONE; MALE; MITRAGYNA; PHYTOTHERAPY; SELF MEDICATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 44149100064     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02209.x     Document Type: Article

References (11)

1. Boyer E., Babu K., Macalino G., Compton W. Self-treatment of opioid withdrawal with a dietary supplement, Kratom. Am J Addict 2007 16 : 352 6.
2. Yamamoto L., Horie S., Takayama H., Aimi N., Sakai S. Opioid receptor agonistic characteristics of mytragynine pseudoindoxyl in comparison with mitragyine derived from Thai medicine plant Mytragyna speciosa. Gen Pharmacol 1999 33 : 73 81.
3. Thongpradichote S., Matsumoto K., Tohda M., Takayama H., Aimi N., Saiki S. et al. Identification of opioid receptor subtypes in antinociceptive actions of suprasinally-administratered Mitragynine in mice. Life Sci 1998 62 : 1371 8.
4. Fishbain D., Rosomoff H. Drug abuse, dependence, and addiction in chronic pain patients. Clin J Pain 1992 8 : 77 85.
5. Takayama H., Ishikawa H., Kurihara M., Kitajima M., Aimi N., Ponglux D. Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: discovery of opioid agonists structurally different from other opioid ligands. J Med Chem 2002 45 : 1949 56.
6. Matsumoto K., Mizowaki M., Suchitra T., Murakami Y., Takayama H., Sakai S. Central antinoceptive effects of mitragynine in mice: contributions from noradrenergic and serotonergic systems. Eur J Pharmacol 1996 317 : 75 81.
7. Narita M., Funada M., Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 2001 89 : 1 15.
8. Wills B., Erickson T. Drug- and toxin-associated seizures. Med Clin North Am 2005 89 : 1297 321.
9. Eisenberg D. M., Kessler R. C., Foster C., Norlock F. E., Calkins D. R., Delbanco T. L. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993 328 : 246 52.
10. Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M. et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998 280 : 1569 75.
11. Joranson D., Gilson A., Dahl J., Haddox J. Pain management, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage 2002 23 : 138 47.